243 related articles for article (PubMed ID: 17239166)
41. Characteristic effects of activated human protein C on tissue thromboplastin-induced disseminated intravascular coagulation in rabbits.
Katsuura Y; Aoki K; Tanabe H; Kiyoki M; Funatsu A
Thromb Res; 1994 Nov; 76(4):353-62. PubMed ID: 7871494
[TBL] [Abstract][Full Text] [Related]
42. Effect of Trasylol on fibrin deposition and elimination in the lungs of rats with intravascular coagulation induced by thrombin or thromboplastin.
Diffang C; Saldeen T
Thromb Res; 1974 Sep; 5(3):263-76. PubMed ID: 4548231
[No Abstract] [Full Text] [Related]
43. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
Asakura H; Suga Y; Yoshida T; Ontachi Y; Mizutani T; Kato M; Ito T; Morishita E; Yamazaki M; Miyamoto K; Nakao S
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743
[TBL] [Abstract][Full Text] [Related]
44. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain.
Kim JB; Sig Choi J; Yu YM; Nam K; Piao CS; Kim SW; Lee MH; Han PL; Park JS; Lee JK
J Neurosci; 2006 Jun; 26(24):6413-21. PubMed ID: 16775128
[TBL] [Abstract][Full Text] [Related]
45. Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.
Aoki Y; Ota M; Katsuura Y; Komoriya K; Nakagaki T
Arzneimittelforschung; 2000 Sep; 50(9):809-15. PubMed ID: 11050697
[TBL] [Abstract][Full Text] [Related]
46. Disseminated Intravascular Coagulation.
Boral BM; Williams DJ; Boral LI
Am J Clin Pathol; 2016 Dec; 146(6):670-680. PubMed ID: 28013226
[TBL] [Abstract][Full Text] [Related]
47. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
[TBL] [Abstract][Full Text] [Related]
48. Sepsis and disseminated intravascular coagulation.
Okamoto K; Tamura T; Sawatsubashi Y
J Intensive Care; 2016; 4():23. PubMed ID: 27011792
[TBL] [Abstract][Full Text] [Related]
49. High-mobility Group Box 1 Protein in Pediatric Trauma Patients With Acute Traumatic Coagulopathy or Disseminated Intravascular Coagulation.
Ulusoy E; Duman M; Çağlar A; Küme T; Er A; Akgül F; Çitlenbik H; Yilmaz D; Ören H
J Pediatr Hematol Oncol; 2020 Nov; 42(8):e712-e717. PubMed ID: 32218095
[TBL] [Abstract][Full Text] [Related]
50. Effects of anticoagulant strategies on activation of inflammation and coagulation.
Feistritzer C; Wiedermann CJ
Expert Opin Biol Ther; 2007 Jun; 7(6):855-70. PubMed ID: 17555371
[TBL] [Abstract][Full Text] [Related]
51. Trauma-induced innate immune activation and disseminated intravascular coagulation.
Gando S; Levi M; Toh CH
J Thromb Haemost; 2024 Feb; 22(2):337-351. PubMed ID: 37816463
[TBL] [Abstract][Full Text] [Related]
52. Indoprofen exerts a potent therapeutic effect against sepsis by alleviating high mobility group box 1-mediated inflammatory responses.
Bi X; Yan X; Jiang B; Liang J; Zhou J; Lu S; Liu J; Luo L; Yin Z
Toxicol Appl Pharmacol; 2021 Dec; 433():115778. PubMed ID: 34755645
[TBL] [Abstract][Full Text] [Related]
53. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
[TBL] [Abstract][Full Text] [Related]
54. Soluble thrombomodulin purified from human urine exhibits a potent anticoagulant effect in vitro and in vivo.
Takahashi Y; Hosaka Y; Niina H; Nagasawa K; Naotsuka M; Sakai K; Uemura A
Thromb Haemost; 1995 May; 73(5):805-11. PubMed ID: 7482407
[TBL] [Abstract][Full Text] [Related]
55. Peptidoglycan induces disseminated intravascular coagulation in baboons through activation of both coagulation pathways.
Popescu NI; Silasi R; Keshari RS; Girton A; Burgett T; Zeerleder SS; Gailani D; Gruber A; Lupu F; Coggeshall KM
Blood; 2018 Aug; 132(8):849-860. PubMed ID: 29921614
[TBL] [Abstract][Full Text] [Related]
56. Extracellular Histones Increase Tissue Factor Activity and Enhance Thrombin Generation by Human Blood Monocytes.
Gould TJ; Lysov Z; Swystun LL; Dwivedi DJ; Zarychanski R; Fox-Robichaud AE; Liaw PC;
Shock; 2016 Dec; 46(6):655-662. PubMed ID: 27405066
[TBL] [Abstract][Full Text] [Related]
57. Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia.
Nagato M; Okamoto K; Abe Y; Higure A; Yamaguchi K
Crit Care Med; 2009 Jul; 37(7):2181-6. PubMed ID: 19487933
[TBL] [Abstract][Full Text] [Related]
58. PF-04886847 (an inhibitor of plasma kallikrein) attenuates inflammatory mediators and activation of blood coagulation in rat model of lipopolysaccharide (LPS)-induced sepsis.
Kolte D; Bryant JW; Gibson GW; Wang J; Shariat-Madar Z
Cardiovasc Hematol Agents Med Chem; 2012 Jun; 10(2):154-66. PubMed ID: 22352684
[TBL] [Abstract][Full Text] [Related]
59. Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital -- meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation.
Cauchie P; Cauchie Ch; Boudjeltia KZ; Carlier E; Deschepper N; Govaerts D; Migaud-Fressart M; Woodhams B; Brohée D
Am J Hematol; 2006 Jun; 81(6):414-9. PubMed ID: 16680742
[TBL] [Abstract][Full Text] [Related]
60. Tissue factor: (patho)physiology and cellular biology.
Eilertsen KE; Østerud B
Blood Coagul Fibrinolysis; 2004 Oct; 15(7):521-38. PubMed ID: 15389118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
